glp-1 drugs alzheimer's failed to slow in two big clinical trials Details of failed studies cast

At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits

Most people notice increased energy, improved mood, and mental clarity within a few days, though results vary depending on your current B12 levels

Test your levels first so the plan matches the actual cause

No mercury

The results suggest that BPC-157 may have improved functional recovery, as indicated by a potential increase in AFI values at all time points